Chapman University

What you'll study

This PhD combines advanced coursework with sustained original research leading to a doctoral dissertation. Core study areas include pharmaceutics and drug delivery, pharmacokinetics and pharmacodynamics, pharmacology and toxicology, pharmacogenomics, clinical outcomes and health services research, and regulatory and administrative aspects of pharmaceutical development.

• Research methods and advanced statistics for pharmaceutical scientists
• Drug formulation, controlled release and nanomedicine
• Molecular pharmacology and mechanisms of drug action
• Pharmacokinetics/pharmacodynamics modelling and bioanalysis
• Pharmacogenetics and precision medicine approaches
• Clinical trial design, regulatory affairs and pharmacoeconomics
• Responsible conduct of research, ethics and scientific communication

Programme structure typically includes initial coursework and laboratory rotations, qualifying examinations to confirm readiness for independent research, a period of focused dissertation research under a faculty advisor, seminar attendance and teaching or mentoring responsibilities. Students work closely with faculty on funded projects and often collaborate with clinical or industry partners for translational research opportunities.

Entry requirements

Successful applicants commonly hold a relevant master’s degree or a professional degree such as a PharmD, MD or an honours degree in pharmaceutical sciences, chemistry, biomedical sciences or a closely related field. Typical application components include:

• A strong academic transcript showing preparedness for graduate-level research
• A detailed statement of research interests outlining proposed doctoral research
• Curriculum vitae demonstrating laboratory or clinical research experience
• Letters of recommendation from academic or professional referees
• Evidence of English language proficiency for international applicants where required

Some applicants may also be asked to provide samples of scholarly writing or to participate in an interview with prospective supervisors. Admission is competitive and selection emphasises research potential and fit with faculty expertise. Funding is often available through research assistantships, teaching assistantships or faculty grants, and applicants are encouraged to discuss opportunities with potential supervisors.

Career prospects

Graduates of this PhD proceed to a range of roles in academia, industry and the public sector. Common career paths include:

• Academic research and faculty positions in universities and medical schools
• Research and development roles in pharmaceutical and biotechnology companies
• Clinical research scientist roles in contract research organisations and hospitals
• Regulatory science and policy roles in governmental agencies and health authorities
• Medical affairs, pharmacovigilance and drug safety positions
• Scientific consulting, medical writing and product development management

The programme emphasises transferable skills such as experimental design, data analysis, grant writing and leadership, preparing graduates to lead multidisciplinary teams and translate discoveries to clinical application or commercial development.

Why study at Chapman University

Chapman University offers doctoral training within a campus environment that supports close faculty-student mentorship and collaborative research. Students benefit from access to contemporary laboratory facilities and cross-disciplinary links with health sciences, chemistry and business disciplines. Being in Southern California provides proximity to a large biotechnology and pharmaceutical ecosystem, enhancing opportunities for industry partnerships, internships and translational projects.

The institution places emphasis on fostering professional development, ethical research practices and communication skills, helping graduates move into leadership roles. Prospective students are encouraged to review faculty research interests and contact potential supervisors to identify strong matches for doctoral study and funding.